Capula Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-4,800
Closed -$247K 893
2025
Q2
$247K Buy
+4,800
New +$241K ﹤0.01% 329
2023
Q2
Sell
-3,630
Closed -$269K 767
2023
Q1
$269K Sell
3,630
-7,544
-68% -$581K ﹤0.01% 546
2022
Q4
$926K Sell
11,174
-706
-6% -$56.1K 0.01% 459
2022
Q3
$843K Buy
+11,880
New +$1.03M 0.01% 428
2021
Q3
Sell
-3,348
Closed -$377K 1053
2021
Q2
$377K Buy
+3,348
New +$352K 0.01% 522

Other funds holding TECH

Capula Management's TECH Position: Q3 2025 in Review

Capula Management sold out of Bio-Techne (TECH) in Q3 2025, closing a stake of 4,800 shares — an estimated $247K sold.

Capula Management first reported a position in TECH in Q2 2021 and held it in 5 quarters. The position peaked at $926K in Q4 2022. 576 funds tracked by Wall St. Rank hold TECH as of Q3 2025.

  • Capula Management reported no remaining Bio-Techne position as of Q3 2025 after selling out during the quarter.
  • Capula Management sold 4,800 Bio-Techne shares in Q3 2025, an estimated $247K.
  • Capula Management first reported a position in Bio-Techne in Q2 2021 and held it in 5 quarters.
  • Capula Management's Bio-Techne position peaked at $926K in Q4 2022.
  • 576 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2025.

Based on Capula Management's 13F filing for Q3 2025, filed 14 Nov 2025.